COVID-19 and Pneumolysis Simulating Extreme High-altitude Exposure with Altered Oxygen Transport Physiology; Multiple Diseases, and Scarce Need of Ventilators: Andean Condor's-eye-view.
| dc.contributor.author | Zubieta-Calleja, Gustavo | |
| dc.contributor.author | Zubieta-DeUrioste, Natalia | |
| dc.contributor.author | Venkatesh, Thuppil | |
| dc.contributor.author | Das, Kusal K | |
| dc.contributor.author | Soliz, Jorge | |
| dc.coverage.spatial | Bolivia | |
| dc.date.accessioned | 2026-03-24T15:04:26Z | |
| dc.date.available | 2026-03-24T15:04:26Z | |
| dc.date.issued | 2020 | |
| dc.description | Vol. 15, No. 4, pp. 347-359 | |
| dc.description.abstract | BACKGROUND: Critical hypoxia in this COVID-19 pandemic results in high mortality and economic loss worldwide. Initially, this disease' pathophysiology was poorly understood and interpreted as a SARS (Severe Acute Respiratory Syndrome) pneumonia. The severe atypical lung CAT scan images alerted all countries, including the poorest, to purchase lacking sophisticated ventilators. However, up to 88% of the patients on ventilators lost their lives. It was suggested that COVID-19 could be similar to a High-Altitude Pulmonary Edema (HAPE). New observations and pathological findings are gradually clarifying the disease. METHODS: As high-altitude medicine and hypoxia physiology specialists working and living in the highlands for over 50 years, we perform a perspective analysis of hypoxic diseases treated at high altitudes and compare them to Covid-19. Oxygen transport physiology, SARS-Cov-2 characteristics, and its transmission, lung imaging in COVID-19, and HAPE, as well as the causes of clinical signs and symptoms, are discussed. RESULTS: High-altitude oxygen transport physiology has been systematically ignored. COVID-19 signs and symptoms indicate a progressive and irreversible failure in the oxygen transport system, secondary to pneumolysis produced by SARS-Cov-2's alveolar-capillary membrane "attack". HAPE's pulmonary compromise is treatable and reversible. COVID-19 is associated with several diseases, with different individual outcomes, in different countries, and at different altitudes. CONCLUSIONS: The pathophysiology of High-altitude illnesses can help explain COVID-19 pathophysiology, severity, and management. Early diagnosis and use of EPO, acetylsalicylic-acid, and other anti-inflammatories, oxygen therapy, antitussives, antibiotics, and the use of Earth open-circuit- astronaut-resembling suits to return to daily activities, should all be considered. Ventilator use can be counterproductive. Immunity development is the only feasible long-term survival tool. | eng |
| dc.description.sponsorship | High Altitude Pulmonary and Pathology Institute (HAPPI-IPPA), Av. Copacabana - Prolongacion # 55, La Paz, Bolivia. | High Altitude Pulmonary and Pathology Institute (HAPPI-IPPA), Av. Copacabana - Prolongacion # 55, La Paz, Bolivia. | High Altitude Pulmonary and Pathology Institute (HAPPI-IPPA), Av. Copacabana - Prolongacion # 55, La Paz, Bolivia. | |
| dc.identifier.doi | 10.2174/1574887115666200925141108 | |
| dc.identifier.issn | 1876-1038 | |
| dc.identifier.other | PMID:32981508 | |
| dc.identifier.uri | https://doi.org/10.2174/1574887115666200925141108 | |
| dc.identifier.uri | https://andeanlibrary.org/handle/123456789/101044 | |
| dc.language.iso | eng | |
| dc.relation.ispartof | Reviews on recent clinical trials | |
| dc.source | PubMed | |
| dc.subject | EPO | |
| dc.subject | HAPE | |
| dc.subject | Polyerythrocythemia | |
| dc.subject | SARS-Cov-2 | |
| dc.subject | coronavirus suit | |
| dc.subject | tolerance to hypoxia | |
| dc.title | COVID-19 and Pneumolysis Simulating Extreme High-altitude Exposure with Altered Oxygen Transport Physiology; Multiple Diseases, and Scarce Need of Ventilators: Andean Condor's-eye-view. | |
| dc.type | Artículo Científico Publicado |